Leading today’s tech briefing is news that the US is in talks with India to find a way to manufacture Johnson & Johnson’s Covid-19 vaccine in India. The US is also working on a list of raw materials India needs urgently to boost vaccine production. Also on the programme, VMware gets an Indian-born CEO, and later, we talk to Rajat Verma, an entrepreneur who is keen on making lithium-ion cells in India, not just the batteries that he already manufactures. He explained why making the cells locally is very important, and how a $2.5 billion incentive plan that India approved yesterday, will help
View all episodes
By One Thing Today in Tech
1
11 ratings
Leading today’s tech briefing is news that the US is in talks with India to find a way to manufacture Johnson & Johnson’s Covid-19 vaccine in India. The US is also working on a list of raw materials India needs urgently to boost vaccine production. Also on the programme, VMware gets an Indian-born CEO, and later, we talk to Rajat Verma, an entrepreneur who is keen on making lithium-ion cells in India, not just the batteries that he already manufactures. He explained why making the cells locally is very important, and how a $2.5 billion incentive plan that India approved yesterday, will help